Northwest Biotherapeutics Inc (OTCQB:NWBO)

0.288
Delayed Data
As of Feb 23
 -0.012 / -4.00%
Today’s Change
0.14
Today|||52-Week Range
0.43
+22.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues809.0K1.5M1.7M623.0K
 
 
 
 
 
Depreciation And Amortization12.0K11.0K56.0K189.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses56.3M102.6M128.0M79.7M
 
 
 
 
 
Research And Development43.9M85.6M103.1M60.1M
 
 
 
 
 
Total Operating Expenses56.3M102.6M128.0M79.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-55.5M-101.1M-126.3M-79.3M
 
 
 
 
 
Extraordinary Credit1.2M449.0K15.7M17.9M
 
 
 
 
 
Extraordinary Charge-10.6M-34.0M0.00-8.3M
 
 
 
 
Interest Expense On Debt873.0K996.0K4.2M3.8M
 
 
 
 
 
Other Expenses-1.0K23.0K20.0K-6.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-65.8M-135.6M-114.7M-80.2M
 
 
 
 
 
Net Income-65.8M-135.6M-114.7M-85.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.9M59.2M77.7M111.1M
 
 
 
 
 
Shares To Calculate EPS Diluted32.9M59.2M77.7M111.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.00-$2.29-$1.48-$0.77
 
 
 
 
 
EPS Diluted-$2.00-$2.29-$1.48-$0.77